These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34871513)

  • 21. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
    Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
    Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
    Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Feng C; Liu Y; Wang L; Niu D; Han B
    Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
    Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
    Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
    Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
    Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
    Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
    Zhao XT; Zhang CF; Liu QJ
    BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
    Zhan B; Huang X; Jiang L; Bao H; Cheng X
    Angiology; 2018 Aug; 69(7):568-573. PubMed ID: 28950711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over study.
    Ito N; Nanto S; Doi Y; Kurozumi Y; Natsukawa T; Shibata H; Morita M; Kawata A; Tsuruoka A; Sawano H; Okada K; Sakata Y; Kai T; Hayashi T
    Cardiovasc Drugs Ther; 2013 Aug; 27(4):279-87. PubMed ID: 23722418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
    Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
    Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
    Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
    Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
    Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical effect of nicorandil on perioperative myocardial protection in patients undergoing elective PCI: A Systematic Review and Meta-Analysis.
    Ye Z; Su Q; Li L
    Sci Rep; 2017 Mar; 7():45117. PubMed ID: 28322321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandil.
    Ito N; Nanto S; Doi Y; Sawano H; Masuda D; Yamashita S; Okada K; Kaibe S; Hayashi Y; Kai T; Hayashi T
    Circ J; 2010 May; 74(5):909-15. PubMed ID: 20234097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Ji Z; Zhang R; Lu W; Ma G; Qu Y
    Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: A triple-blind, randomized, placebo-controlled study.
    Suleimani HF; Eshraghi A; Daloee MH; Hoseini S; Nakhaee N
    Electron Physician; 2017 Aug; 9(8):4934-4941. PubMed ID: 28979725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Matsubara T; Murohara T
    Diabetes Care; 2006 Feb; 29(2):202-6. PubMed ID: 16443860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
    Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
    Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis.
    Zhou J; Xu J; Cheng A; Li P; Chen B; Sun S
    J Int Med Res; 2020 Nov; 48(11):300060520967856. PubMed ID: 33249959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.